2-year Postdoc in Oral Digitalisation and Characterisation
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Måløv
Are you looking for an opportunity to apply your formulation skills to develop novel (oral) drug delivery systems for treating serious chronic diseases? Then this may be your opportunity to kickstart an exciting career in a global R&D organisation. We are seeking a talented postdoc to work within the EU-funded Horizon Europe program, BUCCAL-PEP. Apply now! The position The position is a 2-year (fixed term) postdoc as part of the Horizon Europe project, BUCCAL-PEP. The project will focus on designing and evaluating mechanistic pre-clinical in vitro and in vivo models to study absorption of a GLP-1 analogue following buccal and oral administration, in a comparative manner. Ideally, the designed models will provide key information relevant to developing buccal and oral drug delivery systems for biologics. The postdoc will work closely with stakeholders within R&ED at Novo Nordisk, in addition to collaborators as part of the BUCCAL-PEP consortium. The Horizon Europe 'BUCCAL-PEP' project aims at developing a multifunctional biomaterial patch to allow, for the first time ever, delivery of peptide therapies across the cheek (buccal). Existing buccal patches, traditionally designed for small molecules, cannot effectively deliver peptides. Type 2 diabetic patients in particular need appropriate peptides administered by convenient routes to treat their disease and improve adherence to therapy. To tackle this economic and personal health burden, BUCCAL-PEP will enable novel peptide-based treatments to emerge and potentially reach the market. The BUCCAL-PEP consortium has seven partners: University College Dublin (UCD) (Dublin, Ireland); Adhex Pharma (Dijon, France); Cambridge Innovation Technologies Consulting Limited (Cambridge UK); Catalyze Innovation Consulting (Amsterdam, The Netherlands); Charite, Berlin Institute of Health (Berlin, Germany); Technical University of Denmark (Copenhagen, Denmark); Novo Nordisk (Greater Copenhagen, Denmark).We provide you with a broad range of exciting work challenges and the opportunity to become part of a workplace with an informal working environment and an active culture of cross-functional collaboration. You will have a unique possibility for professional and scientific development, and the chance to integrate into a dynamic team of highly qualified and enthusiastic colleagues. Qualifications Relevant Ph.D. degree in pharmaceutical sciences, engineering, or similar education. Hands-on experience in advanced in vitro release and permeation techniques. Knowledge and expertise in preclinical in vivo models (rodents, dogs and/or pigs) as well as experience with in vitro/in vivo correlation (IVIVC) and modelling. Basic skills in chromatography and drug analysis are considered as an advantage. Excellent written and spoken English is a must as you will be working in an international environment. As a person, you have strong collaboration and stakeholder management skills, a proactive, positive attitude, and a sense of humour.About the department Oral Digitalisation and Characterisation is part of the Oral Delivery Technologies area at Novo Nordisk, an ambitious and international research team based in Måløv, Denmark. Our collective goal is to develop orally delivered biologics, which can ultimately improve the lives of patients with serious chronic diseases. Here you’ll find a scientific environment that encourages innovation and ingenuity and provides the opportunity to work closely alongside highly skilled scientists to develop the next generation of oral biologics.The department consists of 10 highly skilled employees divided into 8 scientists at all levels and seniority and 2 experienced lab technicians. We aspire to drive innovation by applying cutting-edge technology and formulation expertise, and we are currently transforming the way we work by implementing automated workflows and using data science.Research & Development is vital to Novo Nordisk’s continuous growth. We combine world-class scientific, pharmaceutical, and clinical expertise with the highest ethical standards to continue to improve the quality of life of millions of patients across the world. Therefore, we give you the opportunity to bring your personal ambition and passion to work to improve the quality of life of our patients.Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development to manufacturing, marketing and sales – we’re all working to move the needle on patient care.Contact If you have any questions, please feel free to contact Damiano La Zara at +45 3448 4054 or Ragna Berthelsen at +45 3448 8072.Deadline The application deadline is January 15th, 2024, but you are encouraged to apply as soon as possible, as the applications will be screened on an ongoing basis. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your CV. Please avoid the use of photos in your CV. This makes for a better and less biased process. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Øvrige", og befinder sig i kategorien "Øvrige stillinger".
Arbejdsstedet er beliggende i Måløv.
Jobbet er oprettet på vores service den 15.12.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Øvrige
- Måløv
Lignende jobs
-
Restaurant Manager, Restaurant Ansvar at Scandic S...
Fri kontaktJob Description. If you are ambitious, goal-oriented and not afraid to clear habitual thinking off the table, then we believe that you are our new Restaurant Manager for Restaurant Ansvar, Scandic Spectrum. We know that you take responsibility and have peace of mind with the full overview.Få mere info- Øvrige
- København
-
Restaurant Manager til Restaurant Ansvar, Scandic ...
Fri kontaktEr du ambitiøs, målrettet og ikke bange for at rydde vanetænkning af bordet, så tror vi på, at du er vores nye Restaurant Manager til Restaurant Ansvar, Scandic Spectrum. Vi ved, at du ta’r ansvar og har ro i maven med det fulde overblik. Du er god til at organisere, købe ind, lede og dele din viden.Få mere info- Øvrige
- København
-
Conference Host, fuldtid, Scandic Sluseholmen
Fri kontaktGriber du mulighederne, har overblik og er god til at guide vores gæster, så tror vi på, at du er vores nye Conference Host på Scandic Slusenholmen. Vi ved, at du brænder for at gøre en forskel og har fokus på detaljerne. Og vi ved, at du får tingene til at ske og gerne sætter overliggeren lidt højere for at skabe en succes.Få mere info- Øvrige
- København
Statistik over udbudte jobs som øvrige i Måløv
Herunder ser du udviklingen i udbudte øvrige i Måløv over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal øvrige.
Se flere statistikker her:
Statistik over udbudte øvrige i Måløv over tid
| Dato | Alle jobs som øvrige |
|---|---|
| 7. november 2024 | 10 |
| 6. november 2024 | 11 |
| 5. november 2024 | 11 |
| 4. november 2024 | 9 |
| 3. november 2024 | 10 |
| 2. november 2024 | 10 |
| 1. november 2024 | 11 |
| 31. oktober 2024 | 11 |
| 30. oktober 2024 | 11 |
| 29. oktober 2024 | 11 |
| 28. oktober 2024 | 11 |
| 27. oktober 2024 | 13 |
| 26. oktober 2024 | 13 |
| 25. oktober 2024 | 13 |
| 24. oktober 2024 | 13 |
| 23. oktober 2024 | 11 |
| 22. oktober 2024 | 11 |
| 21. oktober 2024 | 10 |
| 20. oktober 2024 | 11 |
| 19. oktober 2024 | 11 |
| 18. oktober 2024 | 10 |
| 17. oktober 2024 | 11 |
| 16. oktober 2024 | 9 |
| 15. oktober 2024 | 10 |
| 14. oktober 2024 | 8 |
| 13. oktober 2024 | 9 |
| 12. oktober 2024 | 9 |
| 11. oktober 2024 | 8 |
| 10. oktober 2024 | 8 |
| 9. oktober 2024 | 8 |
| 8. oktober 2024 | 7 |